When the expression of the neural marker MAP2 was silenced in human CRC cells, the growth of xenograft tumors was correspondingly inhibited in mouse models, indicating the importance of neurogenic markers in CRC [7]. The gene discussed is MAP2; the disease is colorectal carcinoma.